Phreesia Inc is a healthcare technology company that focuses on transforming the patient experience. It provides a software platform designed to streamline patient intake processes, enhance communication between patients and healthcare providers, and improve overall administrative efficiency within medical practices. By offering solutions such as patient surveys, appointment scheduling, and payment processing, Phreesia aims to optimize workflows, increase patient engagement, and ultimately contribute to better health outcomes. The company is committed to empowering both patients and providers through innovative technology that enhances the healthcare journey. Read More
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
The law firm of Kirby McInerney LLP reminds Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE:PHR) investors of the July 13, 2026 lead plaintiff deadline to seek lead plaintiff appointment in the class action filed on behalf of investors who acquired Phreesia securities between May 8, 2025 through March 30, 2026 (“the Class Period”).
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Phreesia (PHR) To Contact Him Directly To Discuss Their Options
Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming July 13, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Phreesia Inc. (“Phreesia” or the “Company”) (NYSE: PHR) common stock between May 8, 2025 and March 30, 2026, inclusive (the “Class Period”).
Law Offices of Howard G. Smith reminds investors of the upcoming July 13, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Phreesia Inc. (“Phreesia” or the “Company”) (NYSE: PHR) common stock between May 8, 2025 and March 30, 2026, inclusive (the “Class Period”).
Phreesia (NYSE: PHR) shares rose in pre-market trading after better-than-expected sales results. Other gainers include Snowflake, Genius Group, and Astrotech.
Phreesia (NYSE:PHR) reported higher first-quarter revenue and profitability for fiscal 2027, with executives pointing to growth in payment solutions, expanding opportunities from its AccessOne acquisition and continued investment in patient intake, provider engagement and artificial intelligence.
O
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Phreesia Inc. (“Phreesia” or the “Company”) (NYSE: PHR) common stock between May 8, 2025 and March 30, 2026, inclusive (the “Class Period”). Phreesia investors have until July 13, 2026 to file a lead plaintiff motion.
NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE:PHR) investors of the July 13, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. Courts do not consider applications filed after this deadline. The lead plaintiff oversees the litigation on behalf of the class and may influence key decisions, including litigation strategy and settlement. Courts regularly appoint individual investors as lead plaintiffs, not only institutions.
NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Phreesia Inc. (“Phreesia” or the “Company”) (NYSE: PHR) common stock between May 8, 2025 and March 30, 2026, inclusive (the “Class Period”). Phreesia investors have until July 13, 2026 to file a lead plaintiff motion.
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired Phreesia Inc. (“Phreesia” or the “Company”) (NYSE: PHR) common stock between May 8, 2025 and March 30, 2026, inclusive (the “Class Period”). Phreesia investors have until July 13, 2026 to file a lead plaintiff motion.
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Phreesia Inc. (“Phreesia” or the “Company”) (NYSE: PHR) investors concerning the Company’s possible violations of the federal securities laws.
LOS ANGELES, May 22, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Phreesia, Inc. (“Phreesia” or “the Company”) (NYSE: PHR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Law Offices of Howard G. Smith announces an investigation on behalf of Phreesia Inc. (“Phreesia” or the “Company”) (NYSE: PHR) investors concerning the Company’s possible violations of federal securities laws.
